| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human apolipoprotein E (APOE). from ORIGENE TECHNOLOGIES | TP723016 | 100 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein H (beta-2-glycoprotein I) (APOH) from ORIGENE TECHNOLOGIES | TP720364 | 10 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein H (beta-2-glycoprotein I) (APOH) from ORIGENE TECHNOLOGIES | TP305017 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein L, 1 (APOL1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP311114 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein L, 2 (APOL2), transcript variant alpha from ORIGENE TECHNOLOGIES | TP302585 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein L, 3 (APOL3), transcript variant alpha/c from ORIGENE TECHNOLOGIES | TP308643 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein L, 2 (APOL2), transcript variant beta from ORIGENE TECHNOLOGIES | TP316858 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein M (APOM) from ORIGENE TECHNOLOGIES | TP304679 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apolipoprotein O (APOO), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301451 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apoptosis antagonizing transcription factor (AATF), full length from ORIGENE TECHNOLOGIES | TP710286 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apoptosis, caspase activation inhibitor (AVEN) from ORIGENE TECHNOLOGIES | TP303707 | 20 ug | ORIGENE TECHNOLOGIES |
| Human apoptosis enhancing nuclease (AEN) from ORIGENE TECHNOLOGIES | TP302285 | 20 ug | ORIGENE TECHNOLOGIES |
| Cyb561d2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504065 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5d1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504067 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5d2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504068 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB561 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410615 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb561 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504062 | 1 kit | ORIGENE TECHNOLOGIES |
| CYBRD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409455 | 1 kit | ORIGENE TECHNOLOGIES |
| Cybrd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504076 | 1 kit | ORIGENE TECHNOLOGIES |
| CYBRD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309455 | 10 ug | ORIGENE TECHNOLOGIES |
| CYB5R3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401592 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB5R4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405203 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB5R1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405833 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB5R2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417261 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5r1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504069 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5r2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504070 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5r3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504071 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5r4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504072 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB5RL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409968 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyb5rl - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504073 | 1 kit | ORIGENE TECHNOLOGIES |
| CYB5R1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305833 | 10 ug | ORIGENE TECHNOLOGIES |
| CYB5R2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH317261 | 10 ug | ORIGENE TECHNOLOGIES |
| CYB5R3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301592 | 10 ug | ORIGENE TECHNOLOGIES |
| CYB5R3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH317552 | 10 ug | ORIGENE TECHNOLOGIES |
| CYB5R4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305203 | 10 ug | ORIGENE TECHNOLOGIES |
| CYC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404545 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504077 | 1 kit | ORIGENE TECHNOLOGIES |
| Cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405050 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 3 from ORIGENE TECHNOLOGIES | LY422572 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425474 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 4 from ORIGENE TECHNOLOGIES | LY422573 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 4 from ORIGENE TECHNOLOGIES | LY425475 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic nucleotide gated channel alpha 1 (CNGA1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400028 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic nucleotide gated channel alpha 4 (CNGA4) from ORIGENE TECHNOLOGIES | LY421949 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420024 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429061 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421573 | 100 ug | ORIGENE TECHNOLOGIES |
| 2', 3'-cyclic nucleotide 3' phosphodiesterase (CNP) from ORIGENE TECHNOLOGIES | LY409699 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin A2 (CCNA2) from ORIGENE TECHNOLOGIES | LY400494 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin A1 (CCNA1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401287 | 100 ug | ORIGENE TECHNOLOGIES |